New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug ...

Students have access to a wide range of substance abuse resources that include educational opportunities, skill development and intervention support, accompanied by regular programming promoting a ...

A study has found that glucagon-like peptide-1 (GLP-1) class obesity treatments, such as ‘Wegovy,’ may slow the rate of alcohol absorption. By delaying alcohol absorption, they reportedly reduce ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Popular weight loss drugs, like semaglutide (Ozempic, Wegovy) and liraglutide (Victoza), have transformed the way doctors treat diabetes and obesity. Now research suggests these meds — part of a class ...

A class of powerful drugs can dramatically change people’s body weight. But one of the drugs’ most alluring jobs may happen in a spot that’s harder to see: the brain. Some people taking drugs such as ...